A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer
View ORCID ProfileBryan C. Szeglin, Chao Wu, Michael R. Marco, Hyun Sung Park, Zeda Zhang, Bing Zhang, Julio Garcia-Aguilar, R. Daniel Beauchamp, Xi Chen, View ORCID ProfileJ. Joshua Smith
doi: https://doi.org/10.1101/2020.02.16.20023663
Bryan C. Szeglin
aColorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
hAlbert Einstein College of Medicine, Bronx, New York
Chao Wu
aColorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
bHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
Michael R. Marco
aColorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
Hyun Sung Park
aColorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
cWeill Cornell Medical College, New York, New York
Zeda Zhang
dGerstner Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York
Bing Zhang
eDepartment of Molecular and Human Genetics and the Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas
Julio Garcia-Aguilar
aColorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
R. Daniel Beauchamp
fSection of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
Xi Chen
gDivision of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida
J. Joshua Smith
aColorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
bHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
Article usage
Posted February 20, 2020.
A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer
Bryan C. Szeglin, Chao Wu, Michael R. Marco, Hyun Sung Park, Zeda Zhang, Bing Zhang, Julio Garcia-Aguilar, R. Daniel Beauchamp, Xi Chen, J. Joshua Smith
medRxiv 2020.02.16.20023663; doi: https://doi.org/10.1101/2020.02.16.20023663
A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer
Bryan C. Szeglin, Chao Wu, Michael R. Marco, Hyun Sung Park, Zeda Zhang, Bing Zhang, Julio Garcia-Aguilar, R. Daniel Beauchamp, Xi Chen, J. Joshua Smith
medRxiv 2020.02.16.20023663; doi: https://doi.org/10.1101/2020.02.16.20023663
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2961)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4604)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (472)
- Neurology (4384)
- Nursing (237)
- Nutrition (641)
- Oncology (2282)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6969)
- Radiology and Imaging (1537)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)